This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Biogen International Neuroscience Gmbh, Unversität Zürich. Active years: 2017-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 12 
3 out of 276 
Years Active: 2017-2021
Title: Janaky Coomaraswamy: Innovating in TDP-43 Research
Introduction
Janaky Coomaraswamy is a prominent inventor located in Zurich, Switzerland, known for her innovative work in the field of neuroscience. With a portfolio that includes three patents, she has made significant contributions to our understanding and treatment of diseases associated with TAR DNA-binding protein of 43 kDa (TDP-43).
Latest Patents
Her latest patents focus on TDP-43 specific binding molecules. These include various polypeptides such as human antibodies, along with fragments, derivatives, and variants thereof. The patents also detail methods related to these TDP-43 specific binding molecules. Additionally, assays, kits, and solid supports for TDP-43-specific binding molecules are disclosed. These innovations can be utilized in pharmaceutical and diagnostic compositions aimed at TDP-43 targeted immunotherapy and diagnosis, addressing pressing medical needs.
Career Highlights
Janaky Coomaraswamy has had an impressive career, working with reputable organizations such as Biogen International Neuroscience GmbH and the University of Zürich. Her research has substantially influenced the development of therapeutic strategies that target neurological disorders linked to TDP-43 dysfunction.
Collaborations
Throughout her career, Janaky has collaborated with notable scientists in her field, including Roger Nitsch and Christoph Hock. These collaborations have bolstered her research efforts and contributed to advancing the knowledge of TDP-43 related diseases.
Conclusion
In conclusion, Janaky Coomaraswamy stands out as an influential inventor in neuroscience, particularly through her innovative work on TDP-43 specific binding molecules. Her patents represent a significant step towards better diagnostics and therapies, paving the way for advancements that can have a profound impact on patient care in the realm of neurological diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile